Hyperemesis gravidarum and maternal cancer risk, a scandinavian nested case-control study

International Journal of Cancer

Volumn 137, Issue 5, 2015, Pages 1209-1216

  Vandraas, Kathrine F ^a,b   Grjibovski, Andrej M ^b,c,d   Støer, Nathalie C ^e   Troisi, Rebecca ^f   Stephansson, Olof ^e,g   Ording, Anne Gulbech ^h   Vangen, Siri ^a   Grotmol, Tom ⁱ   Vikanes, Åse V ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c KHOJA AKHMET YASSAWI INTERNATIONAL KAZAKH TURKISH UNIVERSITY   (Kazakhstan)

^d NORTHERN STATE MEDICAL UNIVERSITY   (Russian Federation)

^e KAROLINSKA INSTITUTE   (Sweden)

^f NATIONAL CANCER INSTITUTE   (United States)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁱ CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

cancer; hyperemesis; nested case control; registry based

Indexed keywords

CHORIONIC GONADOTROPIN;

ADULT; ARTICLE; BONE CANCER; BREAST CANCER; CANCER CLASSIFICATION; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DENMARK; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; EYE CANCER; FEMALE; HUMAN; HYPEREMESIS GRAVIDARUM; LARYNX CANCER; LIP CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MELANOMA; MOUTH CANCER; NORWAY; POPULATION RESEARCH; PRIORITY JOURNAL; RECTUM CANCER; SKIN CANCER; SOFT TISSUE CANCER; SWEDEN; THYROID CANCER; UTERINE CERVIX CANCER; CLASSIFICATION; NEOPLASMS; PREGNANCY; REGISTER; RISK FACTOR; SCANDINAVIA; STATISTICAL MODEL; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; HYPEREMESIS GRAVIDARUM; LOGISTIC MODELS; NEOPLASMS; PREGNANCY; REGISTRIES; RISK FACTORS; SCANDINAVIAN AND NORDIC COUNTRIES; YOUNG ADULT;

EID: 84931577285     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29475     Document Type: Article

References (50)

1. Guan HB, Wu QJ, Gong TT,. Parity and kidney cancer risk: evidence from epidemiologic studies. Cancer epidemiology, biomarkers & prevention: a publication of the american association for cancer research. Cosponsored by the Am Soc Prev Oncol 2013; 22: 2345-53.
2. Reigstad MM, Larsen IK, Myklebust TA, et al., Risk of breast cancer following fertility treatment-a registry based cohort study of parous women in norway. Int J Cancer J 2015; 136: 1140-8.
3. Zhu B, Zou L, Han J, et al., Parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies. Sci Rep 2014; 4: 5313.
4. Innes KE, Byers TE,. Preeclampsia and breast cancer risk. Epidemiology (Cambridge, Mass) 1999; 10: 722-32.
5. Terry MB, Perrin M, Salafia CM, et al., Preeclampsia, pregnancy-related hypertension, and breast cancer risk. Am J Epidemiol 2007; 165: 1007-14.
6. Fairweather DV,. Nausea and vomiting in pregnancy. Am J Obstet Gynecol 1968; 102: 135-75.
7. Brasky TM, Li Y, Jaworowicz DJ Jr., et al., Pregnancy-related characteristics and breast cancer risk. Cancer Causes Control 2013; 24: 1675-85.
8. Enger SM, Ross RK, Henderson B, et al., Breastfeeding history, pregnancy experience and risk of breast cancer. Br J Cancer 1997; 76: 118-23.
9. Verberg MF, Gillott DJ, Al-Fardan N, et al., Hyperemesis gravidarum, a literature review. Human Reprod Update 2005; 11: 527-39.
10. Askling J, Erlandsson G, Kaijser M, et al., Sickness in pregnancy and sex of child. Lancet 1999; 354: 2053
11. Kallen B,. Hyperemesis during pregnancy and delivery outcome: a registry study. Eur J Obstet Gynecol Reprod Biol 1987; 26: 291-302.
12. Jorgensen KT, Nielsen NM, Pedersen BV, et al., Hyperemesis, gestational hypertensive disorders, pregnancy losses and risk of autoimmune diseases in a danish population-based cohort. J Autoimmun 2012; 38: J120-8.
13. Bhaskaran K, Douglas I, Forbes H, et al., Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 2014; 384: P755-65.
14. Lee C, Raffaghello L, Brandhorst S, et al., Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med 2012; 4: 124ra27
15. Allen NE, Key TJ, Appleby PN, et al., Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the european prospective investigation into cancer and nutrition. Cancer Epidemiol Biomark Prev 2007; 16: 1121-7.
16. Durai R, Yang W, Gupta S, et al., The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge. Int J Colorectal Dis 2005; 20: 203-20
17. Renehan AG, Egger M, Minder C, et al., IGF-I, IGF binding protein-3 and breast cancer risk: comparison of 3 meta-analyses. Int J Cancer 2005; 115: 1006-7; author reply 8.
18. Cnattingius S, Ericson A, Gunnarskog J, et al., A quality study of a medical birth registry. Scand J Soc Med 1990; 18: 143-8.
19. Irgens LM,. The medical birth registry of norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 2000; 79: 435-9.
20. Knudsen LB, Olsen J,. The danish medical birth registry. Danish Med Bull 1998; 45: 320
21. Larsen IK, Smastuen M, Johannesen TB, et al., Data quality at the cancer registry of norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer (Oxford, England: 1990) 2009; 45: 1218-31.
22. Storm HH, Michelsen EV, Clemmensen IH, et al., The danish cancer registry-history, content, quality and use. Danish Med Bull 1997; 44: 535-9.
23. Ludvigsson JF, Andersson E, Ekbom A, et al., External review and validation of the swedish national inpatient register. BMC Publ Heal 2011; 11: 450
24. Lynge E, Sandegaard JL, Rebolj M,. The danish national patient register. Scand J Publ Heal 2011; 39: 30-3.
25. Rodien P, Jordan N, Lefevre A, et al., Abnormal stimulation of the thyrotrophin receptor during gestation. Hum Reprod Update 2004; 10: 95-105.
26. Goodwin TM, Montoro M, Mestman JH, et al., The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 1992; 75: 1333-7.
27. Dal Maso L, Bosetti C, La Vecchia C, et al., Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 2009; 20: 75-86.
28. Bolin M, Akerud H, Cnattingius S, et al., Hyperemesis gravidarum and risks of placental dysfunction disorders: a population-based cohort study. BJOG: Int J Obstet Gynaecol 2013; 120: 541-7.
29. Russo IH, Russo J,. Pregnancy-induced changes in breast cancer risk. J Mamm Gland Biol Neoplas 2011; 16: 221-33.
30. Bernstein L, Hanisch R, Sullivan-Halley J, et al., Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomark Prev 1995; 4: 437-40.
31. Erlandsson G, Lambe M, Cnattingius S, et al., Hyperemesis gravidarum and subsequent breast cancer risk. Br J Cancer 2002; 87: 974-6.
32. Lukanova A, Surcel HM, Lundin E, et al., Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer. Int J Cancer 2012; 130: 910-20.
33. Helseth R, Ravlo M, Carlsen SM, et al., Androgens and hyperemesis gravidarum: a case-control study. Eur J Obstet Gynecol Reprod Biol 2014; 175: 167-71.
34. McNamara KM, Moore NL, Hickey TE, et al., Complexities of androgen receptor signalling in breast cancer. Endocr-Relat Cancer 2014; 21: T161-81.
35. Vikanes A, Grjibovski AM, Vangen S, et al., Maternal body composition, smoking, and hyperemesis gravidarum. Ann Epidemiol 2010; 20: 592-8.
36. Parajuli R, Bjerkaas E, Tverdal A, et al., Smoking increases rectal cancer risk to the same extent in women as in men: results from a norwegian cohort study. BMC Cancer 2014; 14: 321
37. Roura E, Castellsague X, Pawlita M, et al., Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int J Cancer 2014; 135: 453-66.
38. Cho YA, Kim J,. Thyroid cancer risk and smoking status: a meta-analysis. Cancer Causes Control 2014; 25: 1187-95.
39. Gandini S, Botteri E, Iodice S, et al., Tobacco smoking and cancer: a meta-analysis. Int J Cancer 2008; 122: 155-64.
40. Kaaks R, Lukanova A,. Effects of weight control and physical activity in cancer prevention: role of endogenous hormone metabolism. Ann N Y Acad Sci 2002; 963: 268-81.
41. Longo VD, Fontana L,. Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol Sci 2010; 31: 89-98.
42. Elias SG, Peeters PH, Grobbee DE, et al., The 1944-1945 dutch famine and subsequent overall cancer incidence. Cancer Epidemiol Biomark Prev 2005; 14: 1981-5.
43. Robsahm TE, Tretli S,. Breast cancer incidence in food- vs.non-food-producing areas in norway: possible beneficial effects of world war II. Br J Cancer 2002; 86: 362-6.
44. Tretli S, Gaard M,. Lifestyle changes during adolescence and risk of breast cancer: an ecologic study of the effect of world war II in norway. Cancer Causes Control 1996; 7: 507-12.
45. Calle EE, Kaaks R,. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-91.
46. Fejzo MS, Poursharif B, Korst LM, et al., Symptoms and pregnancy outcomes associated with extreme weight loss among women with hyperemesis gravidarum. J Women's Health (2002) 2009; 18: 1981-7.
47. van Stuijvenberg ME, Schabort I, Labadarios D, et al., The nutritional status and treatment of patients with hyperemesis gravidarum. Am J Obstet Gynecol 1995; 172: 1585-91.
48. Cedergren M, Brynhildsen J, Josefsson A, et al., Hyperemesis gravidarum that requires hospitalization and the use of antiemetic drugs in relation to maternal body composition. Am J Obstet Gynecol 2008; 198: 412.e1-5.
49. Rochelson B, Vohra N, Darvishzadeh J, et al., Low prepregnancy ideal weight:height ratio in women with hyperemesis gravidarum. J Reprod Med 2003; 48: 422-4.
50. Vikanes A, Magnus P, Vangen S, et al., Hyperemesis gravidarum in the medical birth registry of Norway-a validity study. BMC Preg Childbirth 2012; 12: 115